Healthy Volunteer Study Using 3 Different Formulations of Firategrast

Clinical trial NCT01416363 · COMPLETED

Trial details

NCT number: NCT01416363
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2011-05-20
Primary completion: 2011-09-17
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.